Literature DB >> 2457389

Human angiogenin, an organogenic protein.

J F Riordan1, B L Vallee.   

Abstract

Angiogenin is a 14 kD protein, initially isolated as a tumour-cell secreted product but subsequently found to be a normal constituent of human plasma. It is a potent inducer of blood vessel formation on the chorioallantoic membrane of the chick embryo. Chemical characterization of the protein reveals a remarkable homology to the pancreatic ribonuclease family and has led to the identification of a unique ribonucleolytic activity for angiogenin. It is a particularly potent inhibitor of in vitro protein synthesis. Treatment with placental ribonuclease inhibitor abolishes the biological and enzymatic activities of angiogenin, an effect with important mechanistic, physiological and pharmacologic implications.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2457389      PMCID: PMC2246469          DOI: 10.1038/bjc.1988.133

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  Characteristic ribonucleolytic activity of human angiogenin.

Authors:  R Shapiro; J F Riordan; B L Vallee
Journal:  Biochemistry       Date:  1986-06-17       Impact factor: 3.162

2.  A preliminary three-dimensional structure of angiogenin.

Authors:  K A Palmer; H A Scheraga; J F Riordan; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

3.  Isolation of tumor-secreted products from human carcinoma cells maintained in a defined protein-free medium.

Authors:  E M Alderman; R R Lobb; J W Fett
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

4.  Amino acid sequence of human tumor derived angiogenin.

Authors:  D J Strydom; J W Fett; R R Lobb; E M Alderman; J L Bethune; J F Riordan; B L Vallee
Journal:  Biochemistry       Date:  1985-09-24       Impact factor: 3.162

5.  Sequence of the cDNA and gene for angiogenin, a human angiogenesis factor.

Authors:  K Kurachi; E W Davie; D J Strydom; J F Riordan; B L Vallee
Journal:  Biochemistry       Date:  1985-09-24       Impact factor: 3.162

6.  Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin.

Authors:  R Shapiro; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

7.  Angiogenin abolishes cell-free protein synthesis by specific ribonucleolytic inactivation of ribosomes.

Authors:  D K St Clair; S M Rybak; J F Riordan; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

8.  Ribonuclease inhibitor from human placenta. Purification and properties.

Authors:  P Blackburn; G Wilson; S Moore
Journal:  J Biol Chem       Date:  1977-08-25       Impact factor: 5.157

9.  Ribonucleolytic activity of angiogenin: essential histidine, lysine, and arginine residues.

Authors:  R Shapiro; S Weremowicz; J F Riordan; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

10.  The amino acid sequence of human pancreatic ribonuclease.

Authors:  J J Beintema; P Wietzes; J L Weickmann; D G Glitz
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

View more
  3 in total

1.  Specific binding of angiogenin to calf pulmonary artery endothelial cells.

Authors:  J Badet; F Soncin; J D Guitton; O Lamare; T Cartwright; D Barritault
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

2.  Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities.

Authors:  G Hu; J F Riordan; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

3.  Angiogenin reduces immune inflammation via inhibition of TANK-binding kinase 1 expression in human corneal fibroblast cells.

Authors:  Seung Hoon Lee; Kyoung Woo Kim; Kyong-Mi Min; Kyu-Wan Kim; Soo-Ik Chang; Jae Chan Kim
Journal:  Mediators Inflamm       Date:  2014-04-17       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.